Reaction
Ecthyma reporting signals
As of the last recalculation, Ecthyma appears in 398 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE DELAYED-RELEASE (PRR 74.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Posaconazole Delayed-Release | 15 | 74.2 | 74.3 |
| Pegaspargase | 16 | 71.2 | 71.3 |
| Posaconazole | 15 | 50.1 | 50.2 |
| Methimazole | 7 | 47.4 | 47.5 |
| Valganciclovir Hydrochloride Powder, | 9 | 39.5 | 39.5 |
| Micafungin Sodium | 6 | 37.6 | 37.6 |
| Amphotericin B | 8 | 34.1 | 34.1 |
| Cefepime | 9 | 33.6 | 33.6 |
| Bendamustine Hydrochloride | 7 | 31.1 | 31.1 |
| Cefepime Hydrochloride | 9 | 29.9 | 29.9 |
| Voriconazole Injection | 12 | 29.8 | 29.8 |
| Vincristine Sulfate | 16 | 29.7 | 29.7 |
| Amikacin | 9 | 28.2 | 28.2 |
| Mesna Injection | 4 | 25.6 | 25.6 |
| Mesna | 4 | 25.1 | 25.1 |
| Obinutuzumab | 6 | 19.4 | 19.4 |